Financial News

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Hims & Hers Health, Inc. Class A Common Stock (NY:HIMS)

48.49 +1.03 (+2.17%)
Official Closing Price Updated: 7:00 PM EDT, Oct 23, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Hims & Hers Health, Inc. Class A Common Stock

< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
46 47 Next >
Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up
Can Hims & Hers Health recover after the FDA removed semaglutide from its drugs shortage list? 
Via Investor's Business Daily
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
NVDA Earnings And The State Of The Market
Nvidia reported its much anticipated 4Q earnings after the close. It was a mixed bag. 
Via Talk Markets
Topics Stocks / Equities
Why Hims & Hers Stock Rebounded on Wednesday
Via The Motley Fool
10 Health Care Stocks Whale Activity In Today's Session
 
Via Benzinga
Hims Stock Crashed After Earnings. What Went Wrong?
Via The Motley Fool
Smart Money Is Betting Big In HIMS Options
 
Via Benzinga
Wall Street’s Most Wanted: 2 Highly Shorted Stocks Right Now
See why these two high-flying stocks are among the most shorted in the market, plus counterarguments amid bearish gripes. 
Via MarketBeat
GoodRx Earnings: What To Look For From GDRX
Healthcare tech company GoodRx (NASDAQ:GDRX) will be announcing earnings results tomorrow before the bell. Here’s what investors should know. 
Via StockStory
Dow Surges 200 Points; Keurig Dr Pepper Posts Upbeat Earnings
 
Via Benzinga
Topics Stocks
Hims & Hers Health Analyst Sees Buying Opportunity Following Steep Selloff: 'We See No Reason To Change Our View'
Hims & Hers Health Inc. (NYSE: HIMS) shares dropped sharply after the company reported its fourth-quarter earnings. Here's what you need to know. 
Via Benzinga
Why Hims & Hers Health (HIMS) Shares Are Getting Obliterated Today
Shares of telehealth company Hims & Hers Health (NYSE:HIMS) fell 27.6% in the afternoon session after the company delivered mixed fourth-quarter 2024 results: It added fewer customers than expected,... 
Via StockStory
Which stocks are experiencing notable movement on Tuesday?
Here are the top movers in Tuesday's session, showcasing the stocks with significant price changes. 
Via Chartmill
Bitcoin Plunges As Consumer Confidence Falls: What's Driving Markets Tuesday?
Markets fell broadly Tuesday with the S&P 500 trading at five-week lows and the Nasdaq extending its three-day losing streak. The Dow Jones managed to recover midday while Wall Street digested a... 
Via Benzinga
Topics Stocks
Hims & Hers Stock Crashed 26% Today. Here's What You Need to Know
Hims & Hers grew 95% in the fourth quarter of 2024, but investors were worried about GLP-1 growth. 
Via The Motley Fool
Traders are paying attention to the gapping stocks in Tuesday's session.
Traders are paying attention to the gapping stocks in Tuesday's session. Let's dive into which stocks are experiencing notable gaps. 
Via Chartmill
Hims & Hers Health Stock Is Plunging Tuesday: What's Going On?
Hims & Hers Health reported fourth-quarter revenue of $481.14 million, beating estimates of $470.31 million, according to Benzinga Pro. The company reported fourth-quarter earnings of 11 cents per... 
Via Benzinga
What's going on in today's pre-market session
Before the opening bell on Tuesday, let's take a glimpse of the US markets and explore the top gainers and losers in today's pre-market session. 
Via Chartmill
Tandem Diabetes (TNDM) Q4 Earnings: What To Expect
Diabetes technology company Tandem Diabetes Care (NASDAQ:TNDM) will be reporting earnings tomorrow after the bell. Here’s what to expect. 
Via StockStory
Markets Mostly Dip Red Late In Regular Trading
Market indexes drooped in the final minutes of the normal trading day to start a new week, with all major indexes save the blue-chip Dow closing in the red, adding to Friday’s losses. 
Via Talk Markets
Topics Stocks Stocks / Equities
Hims & Hers Stock Sinks After-Hours As Weight-Loss Roadmap Gets Clouded — Retail Pounces On The Dip
On the earnings call, CEO Andrew Dudum acknowledged that the transition would be "inevitable" for patients currently on compounded semaglutide. 
Via Stocktwits
Topics Earnings
What's going on in today's after hours session
As the regular session of the US market concludes on Monday, let's get an insight into the after-hours session and identify the stocks leading the pack in terms of gains and losses. 
Via Chartmill
Hims & Hers Health Stock Drops After Q4 Report: EPS In-Line, Revenues Beat
Hims & Hers Health reports its fourth-quarter results after Monday's closing bell. Here's a look at the key figures from the quarter. 
Via Benzinga
Hims & Hers Health (NYSE:HIMS) Beats Q4 Sales Targets But Stock Drops 16%
Telehealth company Hims & Hers Health (NYSE:HIMS) announced better-than-expected revenue in Q4 CY2024, with sales up 95.1% year on year to $481.1 million. On top of that, next quarter’s revenue... 
Via StockStory
Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results
From Hims & Hers
Via Business Wire
What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle
Hims & Hers Health is on deck to report its fourth-quarter earnings late Monday. Here's what to expect. 
Via Investor's Business Daily
Palantir Extends Losses, Microsoft Slides: What's Driving Markets Monday?
The major indices struggled to maintain early momentum on Monday, but appear to climbing back with the S&P 500 and Dow Jones both green in midday trading.  
Via Benzinga
Topics Stocks
Earnings Scheduled For February 24, 2025
 
Via Benzinga
Hims & Hers Retail Traders Eye Robust Post-Earnings Rebound Following Stock’s Worst Drop On Semaglutide Update
CEO Andrew Dudum acknowledged retail shareholders in a post on X, highlighting their deep research on the company and announcing plans to engage them directly on future earnings calls. 
Via Stocktwits
Hims & Hers Health (HIMS) To Report Earnings Tomorrow: Here Is What To Expect
Telehealth company Hims & Hers Health (NYSE:HIMS) will be reporting earnings tomorrow afternoon. Here’s what investors should know. 
Via StockStory
< Previous 1 2
...
20 21 22 23 24 25 26 27 28
...
46 47 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Use the myMotherLode.com Keyword Search to go straight to a specific page

Popular Pages

  • Local News
  • US News
  • Weather
  • State News
  • Events
  • Traffic
  • Sports
  • Dining Guide
  • Real Estate
  • Classifieds
  • Financial News
  • Fire Info
Terms of Service Privacy Policy
© Copyright 2000-2019 Clarke Broadcasting Corporation. All rights reserved.
Feedback